UroGen Pharma Ltd. - Ordinary Shares (URGN) Social Stream



UroGen Pharma Ltd. - Ordinary Shares (URGN): $9.23

-0.04 (-0.43%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add URGN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 402

in industry

Featured Post From StockTwits About URGN

$URGN New SEC Filing: 8-K Earnings - UroGen Pharma Ltd. (0001668243) August 04


Item 2.02 Results of Operations and Financial Condition. On August 4, 2021, UroGen Pharma Ltd. (the "Company") announced its financial results for the quarter ended June 30, 2021 in the press release attached hereto as Exhibit 99.1 and incorporated herein by reference. The information in this Item 2.02, including the attached Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange A (...)

https://mkn.re/87426
MarketNewswire, published August 4, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5161 seconds.